Wikipedia -WSS

Wikipedia

author：knowledge 2025-10-03 00:07:23 - browse：36

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： In diabetes hearing, Sanders takes on a new foe: food makers

hotspot

WSS

Maui's cultural, historic landmarks damaged in the devastating wildfires

Wegovy’s successful heart trial raises vital question about weight loss

FDA approves world's first CRISPR

Wegovy’s successful heart trial raises vital question about weight loss

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Police still searching for prisoner who escaped from NYC hospital

leisure time

Wikipedia

hotspot

Sports medicine is finally prioritizing gender equality

Pfizer plans to depart BIO

What does generative AI mean for health care? We asked experts

Pregnancy discrimination could be enabled by AI

Alkermes shareholders re

NIH trials fail to test meaningful long Covid therapies, experts say

Bright Health sells Medicare Advantage business to Molina

Congenital heart disease patients face new threat of heart failure

Duchenne breakthrough therapy leaves behind pioneering families

Pfizer plans to depart BIO

Wikipedia

Americans' trust in science, scientist continues decline: Report

Wegovy’s successful heart trial raises vital question about weight loss

SCOTUS to consider access to abortion pill mifepristone

Patients' immediate access to test results puts radiologists in a bind

Man killed during FBI raid in connection with threats against Biden, other officials

After sickle

hotspot

leisure time

hotspot

focus